Proprotein Convertase Subtilisin-Kexin Type 9 inhibitors and stroke prevention: A meta-analysis.

Proprotein Convertase Subtilisin-Kexin Type 9 inhibitors and stroke prevention: A meta-analysis. Eur J Intern Med. 2021 Jan 05;: Authors: Sagris D, Ntaios G, Georgiopoulos G, Pateras K, Milionis H PMID: 33419661 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33419661?dopt=Abstract

Source: European Journal of Internal Medicine - January 5, 2021 Category: Internal Medicine Authors: Sagris D, Ntaios G, Georgiopoulos G, Pateras K, Milionis H Tags: Eur J Intern Med Source Type: research

More News: Internal Medicine | Science | Stroke